302 related articles for article (PubMed ID: 21110900)
21. [Expression and clinical significance of inducible co-stimulator on peripheral blood T lymphocyte subsets in patients with systemic lupus erythematosus].
Yang JH; Shen Q; Zhao DB; Cai Q; Han XH
Zhonghua Yi Xue Za Zhi; 2005 Feb; 85(5):318-23. PubMed ID: 15854508
[TBL] [Abstract][Full Text] [Related]
22. Effect of CD28 antibody on T cells from patients with systemic lupus erythematosus.
Alvarado C; Alcocer-Varela J; Llorente L; Richaud-Patin Y; Cerbon M; Alarcon-Segovia D
J Autoimmun; 1994 Dec; 7(6):763-73. PubMed ID: 7888034
[TBL] [Abstract][Full Text] [Related]
23. [Analysis of Foxp3+ CD4+ CD25+ regulatory cells in peripheral blood of patients with SLE].
Wei HG; Cai B; Wang LL; Li J; Feng WH
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2007 May; 23(5):432-5. PubMed ID: 17488604
[TBL] [Abstract][Full Text] [Related]
24. Quantitative and functional profiles of CD4+ lymphocyte subsets in systemic lupus erythematosus patients with lymphopenia.
Gómez-Martín D; Díaz-Zamudio M; Vanoye G; Crispín JC; Alcocer-Varela J
Clin Exp Immunol; 2011 Apr; 164(1):17-25. PubMed ID: 21235538
[TBL] [Abstract][Full Text] [Related]
25. Flowcytometric study of expression of perforin and CD134 in patients with systemic lupus erythematosus.
Abo-Elenein A; Shaaban D; Gheith O
Egypt J Immunol; 2008; 15(2):135-43. PubMed ID: 20306696
[TBL] [Abstract][Full Text] [Related]
26. Regulatory T cells and their molecular markers in peripheral blood of the patients with systemic lupus erythematosus.
Hu S; Xiao W; Kong F; Ke D; Qin R; Su M
J Huazhong Univ Sci Technolog Med Sci; 2008 Oct; 28(5):549-52. PubMed ID: 18846336
[TBL] [Abstract][Full Text] [Related]
27. Increased expression of costimulatory markers CD134 and CD80 on interleukin-17 producing T cells in patients with systemic lupus erythematosus.
Dolff S; Quandt D; Wilde B; Feldkamp T; Hua F; Cai X; Specker C; Kribben A; Kallenberg CG; Witzke O
Arthritis Res Ther; 2010; 12(4):R150. PubMed ID: 20653937
[TBL] [Abstract][Full Text] [Related]
28. Regulatory T cells in patients with systemic lupus erythematosus.
Alvarado-Sánchez B; Hernández-Castro B; Portales-Pérez D; Baranda L; Layseca-Espinosa E; Abud-Mendoza C; Cubillas-Tejeda AC; González-Amaro R
J Autoimmun; 2006 Sep; 27(2):110-8. PubMed ID: 16890406
[TBL] [Abstract][Full Text] [Related]
29. [Expression and significance of Th17 and Treg cells in peripheral blood of patients with systemic lupus erythematosus].
Cai XY; Luo M; Lin XJ; Xu YL; Tang C; Ye JH; Li WN; He ZX; Yu N
Zhonghua Yi Xue Za Zhi; 2012 Feb; 92(7):460-3. PubMed ID: 22490966
[TBL] [Abstract][Full Text] [Related]
30. Relationship between T lymphocyte subsets and cortisol in systemic lupus erythematosus.
Shah D; Kiran R; Wanchu A; Bhatnagar A
Kathmandu Univ Med J (KUMJ); 2009; 7(27):213-9. PubMed ID: 20071865
[TBL] [Abstract][Full Text] [Related]
31. The quantitative analysis of peripheral blood FOXP3-expressing T cells in systemic lupus erythematosus and rheumatoid arthritis patients.
Lin SC; Chen KH; Lin CH; Kuo CC; Ling QD; Chan CH
Eur J Clin Invest; 2007 Dec; 37(12):987-96. PubMed ID: 18036033
[TBL] [Abstract][Full Text] [Related]
32. Characteristics and clustering analysis of peripheral blood lymphocyte subsets in children with systemic lupus erythematosus complicated with clinical infection.
Deng Y; Ou YY; Mo CJ; Huang L; Qin X
Clin Rheumatol; 2023 Dec; 42(12):3299-3309. PubMed ID: 37537315
[TBL] [Abstract][Full Text] [Related]
33. mRNA expression of chemokine receptors on peripheral blood mononuclear cells and correlation with clinical features in systemic lupus erythematosus patients.
Li YM; Chen ZQ; Yao X; Yang AZ; Li AS; Liu DM; Gong JQ
Chin Med Sci J; 2010 Sep; 25(3):162-8. PubMed ID: 21180278
[TBL] [Abstract][Full Text] [Related]
34. Circulating lymphocyte subpopulations in patients with systemic lupus erythematosus and their correlation with disease activity.
Yang Z; Yu W; Lu Y
Clin Exp Med; 2023 Dec; 23(8):4757-4763. PubMed ID: 37907622
[TBL] [Abstract][Full Text] [Related]
35. Interleukin 21 correlates with T cell and B cell subset alterations in systemic lupus erythematosus.
Terrier B; Costedoat-Chalumeau N; Garrido M; Geri G; Rosenzwajg M; Musset L; Klatzmann D; Saadoun D; Cacoub P
J Rheumatol; 2012 Sep; 39(9):1819-28. PubMed ID: 22859347
[TBL] [Abstract][Full Text] [Related]
36. Increased interleukin‑9 and CD4+IL-9+ T cells in patients with systemic lupus erythematosus.
Ouyang H; Shi Y; Liu Z; Feng S; Li L; Su N; Lu Y; Kong S
Mol Med Rep; 2013 Mar; 7(3):1031-7. PubMed ID: 23291628
[TBL] [Abstract][Full Text] [Related]
37. Reduction of forkhead box P3 levels in CD4+CD25high T cells in patients with new-onset systemic lupus erythematosus.
Zhang B; Zhang X; Tang F; Zhu L; Liu Y
Clin Exp Immunol; 2008 Aug; 153(2):182-7. PubMed ID: 18505426
[TBL] [Abstract][Full Text] [Related]
38. Assay of T- and NK-cell subsets and the expression of NKG2A and NKG2D in patients with new-onset systemic lupus erythematosus.
Li WX; Pan HF; Hu JL; Wang CZ; Zhang N; Li J; Li XP; Xu JH; Ye DQ
Clin Rheumatol; 2010 Mar; 29(3):315-23. PubMed ID: 20012119
[TBL] [Abstract][Full Text] [Related]
39. The role of T helper cell subsets in pathogenesis of Systemic Lupus Erythematosus and their relation to disease activity.
Al-Saleh J; el-Eissawy S
Egypt J Immunol; 2006; 13(2):41-8. PubMed ID: 18689270
[TBL] [Abstract][Full Text] [Related]
40. Enrichment of circulating interleukin-17-secreting interleukin-23 receptor-positive γ/δ T cells in patients with active ankylosing spondylitis.
Kenna TJ; Davidson SI; Duan R; Bradbury LA; McFarlane J; Smith M; Weedon H; Street S; Thomas R; Thomas GP; Brown MA
Arthritis Rheum; 2012 May; 64(5):1420-9. PubMed ID: 22144400
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]